Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -55.42% | -57.74% | -58.17% | -58.02% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -55.42% | -57.74% | -58.17% | -58.02% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -55.42% | -57.74% | -58.17% | -58.02% | -- |
| SG&A Expenses | 35.47% | 4.15% | 0.91% | -3.69% | -7.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.48% | 21.25% | 17.40% | 12.48% | 6.91% |
| Operating Income | -212.78% | -172.46% | -144.10% | -109.86% | 67.35% |
| Income Before Tax | -258.49% | -206.39% | -132.02% | -86.20% | 70.83% |
| Income Tax Expenses | -109.85% | -109.85% | -172.96% | -179.86% | -- |
| Earnings from Continuing Operations | -252.07% | -201.39% | -117.96% | -71.60% | 70.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -252.07% | -201.39% | -117.96% | -71.60% | 70.31% |
| EBIT | -212.78% | -172.46% | -144.10% | -109.86% | 67.35% |
| EBITDA | -216.08% | -176.26% | -147.92% | -113.03% | 67.43% |
| EPS Basic | -248.85% | -199.96% | -116.24% | -57.23% | 78.53% |
| Normalized Basic EPS | -177.28% | -142.78% | -140.27% | -86.66% | 73.36% |
| EPS Diluted | -248.48% | -199.76% | -116.26% | -57.36% | 78.57% |
| Normalized Diluted EPS | -165.57% | -133.32% | -130.81% | -80.60% | 72.19% |
| Average Basic Shares Outstanding | 1.10% | 0.42% | 0.55% | 4.23% | 22.52% |
| Average Diluted Shares Outstanding | -0.25% | -0.93% | -0.80% | 2.77% | 24.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |